Salk Institute for Biological Studies

  Award Total: $1,641,526 # of Awards: 12 Home Page:

Investigators

  Mark Chapman , Ph.D.- Senyon Choe , Ph.D.- Dannielle Engle , BA- Tony Hunter , Ph.D.- David Liston , Ph.D.- Gordon Louie , Ph.D.- Zhimin Lu , M.D., Ph.D.- Heinz Ruffner , Ph.D.- Inder Verma , Ph.D.- Zhiyong Wang , Ph.D.- Yan Xia , Ph.D.- Wen Xie , M.D., Ph.D.- Quan Zhu , Ph.D.-

Grants

Title[sort] Cycle Award[sort]
Targeting heterochromatic RNAs in high risk breast cancer 2017 (Cycle 23) $291,000
 Investigator(s): Tony Hunter, Ph.D. 23IB-0016
A Genetic System for Identification of Mammary Stem Cells 2009 (Cycle 15) $76,000
 Investigator(s): Dannielle Engle, BA 15GB-0015
Targeting of DNA Methylation in Mammary Epithelial Cells 2004 (Cycle 10) $87,291
 Investigator(s): David Liston, Ph.D. 10FB-0042
Molecular Analysis of BRCA1 Function 2003 (Cycle IX) $85,557
 Investigator(s): Quan Zhu, Ph.D. 9FB-0172
BRCA1-dependent Ubiquitin Ligase Activity in Breast Cancer 2002 (Cycle VIII) $65,297
 Investigator(s): Yan Xia, Ph.D. 8FB-0124
Coactivators in Mammary Gland Development and Tumorigenesis 2001 (Cycle VII) $86,400
 Investigator(s): Zhiyong Wang, Ph.D. 7FB-0040
Tamoxifen-Induced Endometrial Cell Transformation 2000 (Cycle VI) $85,968
 Investigator(s): Zhimin Lu, M.D., Ph.D. 6FB-0108
ACTR/A1B1 in Mammary Gland Development and Tumorigenesis 1999 (Cycle V) $16,178
 Investigator(s): Wen Xie, M.D., Ph.D. 5FB-0117
Biochemical and Functional Characterization of BRCA1 1998 (Cycle IV) $75,445
 Investigator(s): Heinz Ruffner, Ph.D. 4FB-0102
Heregulin-specific Diphtheria Toxin as a Cancer Therapy 1998 (Cycle IV) $322,293
 Investigator(s): Gordon Louie, Ph.D. 4KB-0143
Molecular Analysis of BRCA1 Function 1997 (Cycle III) $75,045
 Investigator(s): Mark Chapman, Ph.D. 3FB-0127
Targeting Breast Cancer Using Diphtheria Toxin 1996 (Cycle II) $375,052
 Investigator(s): Senyon Choe, Ph.D. 2CB-0063